Erkang Pharmaceutical (300267. SZ) plans to increase the production of Chinese herbal extracts in its business scope

On November 14, gronhui Pharmaceutical (300267 SZ) announced that the company held the first meeting of the Fourth Board of directors on November 14, 2019, deliberated and passed the proposal on increasing the business scope and amending it According to the needs of the company's business development, the company plans to increase the business scope and amend the relevant provisions of the articles of association In recent years, the CPC Central Committee and the State Council pay more and more attention to the development of traditional Chinese medicine As a leading enterprise in pharmaceutical accessories industry and practitioner of modern pharmaceutical production technology, the company actively responds to the call of the Party Central Committee, plans to introduce modern pharmaceutical technology and standardized management into the production of traditional Chinese medicine, and strive to achieve the integration of traditional Chinese medicine and Western medicine According to the needs of the above business development, the company will strengthen the research on traditional Chinese medicine and medicine, integrate resources through the combination of endogenous development, extension expansion and cooperative development, and promote the company to make achievements in the field of traditional Chinese medicine cultural heritage and product innovation The company plans to increase the business scope, as follows: Before the change: business scope: manufacturing of chemical raw materials, chemical products, starch and starch products, pharmaceutical special equipment, food additives; sales of pharmaceutical raw materials, pharmaceutical excipients, pharmaceutical capsules, health food, prepackaged food, bulk food, food, food additives; production of pharmaceutical excipients, pharmaceutical capsules; sales and research and development of chemical products; Biotechnology Development service, consultation, exchange service and transfer service; new material technology development service, consultation, exchange service and transfer service; technical research and development, consultation and transfer of pharmaceutical auxiliary materials; self operation and agency of import and export of all kinds of goods and technologies, except those restricted or prohibited by the state; health food research and development; mutual cooperation of drugs and medical devices Internet transaction service; Internet drug transaction; Internet information service for drugs and medical devices; wholesale of mechanical equipment, hardware products and electronic products; retail of general mechanical equipment (for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments) After the change: business scope: manufacturing of chemical raw materials, chemical products, starch and starch products, pharmaceutical special equipment and food additives; sales of pharmaceutical raw materials, pharmaceutical excipients, pharmaceutical capsules, health food, prepackaged food, bulk food, food and food additives; production of pharmaceutical excipients and pharmaceutical capsules; sales and research and development of chemical products; Biotechnology Development service, consultation, exchange service and transfer service; new material technology development service, consultation, exchange service and transfer service; technical research and development, consultation and transfer of pharmaceutical auxiliary materials; self operation and agency of import and export of all kinds of goods and technologies, except those restricted or prohibited by the state; health food research and development; mutual cooperation of drugs and medical devices Internet transaction service; Internet drug transaction; Internet information service of drugs and medical devices; wholesale of mechanical equipment, hardware products and electronic products; retail of general mechanical equipment; Production of Chinese herbal extracts; processing, purchase, sale and storage of Chinese herbal medicines; manufacturing of chemical pharmaceutical preparations; production of Chinese patent medicine; sales of Chinese herbal pieces; processing of Chinese herbal pieces; research and development of Chinese medicine; promotion of Chinese medicine; service of Chinese medicine; cultural service of Chinese Medicine; cultural promotion of Chinese medicine; planting of Chinese herbal medicine (for projects subject to approval according to law, business activities can be carried out only with the approval of relevant departments) articles 25 and 125 of the articles of association are revised in addition to the business scope of Article 13, as follows: Original clause: Article 25 Where the company purchases the shares of the company due to the circumstances specified in Article 23 (1) and (2) of the articles of association, the resolution of the general meeting of shareholders shall be adopted In case of acquisition of the company's shares due to the circumstances specified in Article 23 (3), (5) and (6) of the articles of association, the resolution of the board meeting attended by more than two-thirds of the directors may be adopted in accordance with the provisions of the articles of association or the authorization of the general meeting of shareholders Article 25 Where the company purchases the shares of the company due to the circumstances specified in Article 23 (1) and (2) of the articles of association, the resolution of the general meeting of shareholders shall be adopted In case of acquisition of the company's shares due to the circumstances specified in Article 23 (3), (5) and (6), the resolution of the board meeting attended by more than two-thirds of the directors shall be adopted Article 125 the company has one general manager, one to three deputy general managers, one secretary of the board of directors, one chief financial officer and one chief engineer The above-mentioned personnel are senior management personnel of the company, who are employed and dismissed by the board of directors Article 125 the company has one general manager, two to four deputy general managers, one secretary of the board of directors, one chief financial officer and one chief engineer The above-mentioned personnel are senior management personnel of the company, who are employed and dismissed by the board of directors.